Fact check
Is it true: The Opioid Epidemic?
Yes — this is confirmed.
Purdue Pharma launched OxyContin in 1996 with marketing claiming low addiction risk ("less than 1%") — a claim derived from a 1980 NEJM letter about short-term hospital inpatients, not appropriate evidence for long-term outpatient use. Internal Purdue documents released through litigation showed management was aware of addiction problems by the late 1990s but continued aggressive marketing. The Sackler family extracted over $10B from Purdue as the crisis intensified. Insys Therapeutics (Subsys sublingual fentanyl) executives were convicted of bribing doctors and defrauding insurers (2019). 700,000+ US opioid-related deaths since 1999 (CDC). The 2020 Purdue plea agreement included fraud and kickback conspiracy charges. The 2022 Sackler settlement with DOJ paid ~$6B but granted non-consensual third-party releases — controversial and eventually struck down by SCOTUS 2024.
The claim
The documented large-scale pharmaceutical cover-up of opioid addiction risk by Purdue Pharma (OxyContin), Insys (Subsys), Mallinckrodt, and related firms — contributing to over 700,000 US opioid-relat
Key evidence
OxyContin launched 1996 with low-addiction claim
Prescribing decline but fentanyl drove later deaths
Conspirafy steelmans each claim, then follows the evidence. How we reach a verdict · Check another claim